We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

46 hedge funds and large institutions have $61.1M invested in Assembly Biosciences in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 48 → 46 (-2)

34% less capital invested

Capital invested by funds: $92.3M → $61.1M (-$31.1M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
19
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
QF
QVT Financial
New York
+$1.15M
2
DCM
Dialectic Capital Management
Connecticut
+$317K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$286K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$181K
5
Renaissance Technologies
Renaissance Technologies
New York
+$111K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.48M
2
IHM
Iguana Healthcare Management
New York
-$1.13M
3
GCP
GSA Capital Partners
United Kingdom
-$113K
4
Millennium Management
Millennium Management
New York
-$106K
5
Bank of America
Bank of America
North Carolina
-$91.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$10.5M – – –
Jennison Associates
2
Jennison Associates
New York
$10.2M +$76K +1,136 +0.7%
VAM
3
Visium Asset Management
New York
$8.58M +$55.6K +832 +0.6%
O
4
OrbiMed
New York
$7.01M – – –
PA
5
Perceptive Advisors
New York
$3.99M – – –
QF
6
QVT Financial
New York
$3.05M +$1.15M +17,142 +38%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.37M +$181K +2,701 +7%
RSCM
8
Rock Springs Capital Management
Maryland
$1.96M +$106K +1,583 +5%
BFA
9
BlackRock Fund Advisors
California
$1.92M -$15.8K -236 -0.7%
PI
10
Putnam Investments
Massachusetts
$1.86M – – –
BIT
11
BlackRock Institutional Trust
California
$1.83M -$13.7K -205 -0.7%
Millennium Management
12
Millennium Management
New York
$1.68M -$106K -1,578 -5%
BBA
13
Baker Bros. Advisors
New York
$1.25M – – –
Northern Trust
14
Northern Trust
Illinois
$880K +$3.08K +46 +0.3%
State Street
15
State Street
Massachusetts
$799K +$82.6K +1,235 +10%
DCM
16
Dialectic Capital Management
Connecticut
$286K +$317K +4,739 New
BIM
17
BlackRock Investment Management
Delaware
$265K +$4.61K +69 +2%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$257K +$286K +4,274 New
TCIM
19
TIAA CREF Investment Management
New York
$246K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$230K – – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$208K – – –
William Blair & Company
22
William Blair & Company
Illinois
$205K -$27.9K -417 -11%
Renaissance Technologies
23
Renaissance Technologies
New York
$160K +$111K +1,658 +167%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$155K +$23.4K +350 +16%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$125K +$55.8K +835 +67%
1
2 3

ASMB Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2016, worth a combined $61.1M — down 34% from $92.3M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ASMB and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 19 added.

The largest buyer was QVT Financial, adding an estimated $1.15M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.48M sold.

  • 46 institutional investors held Assembly Biosciences (ASMB) as of Q1 2016, down from 48 in Q4 2015.
  • Funds reported $61.1M of Assembly Biosciences stock for Q1 2016, down 34% quarter-over-quarter.
  • 3 funds opened new Assembly Biosciences positions in Q1 2016 and 5 closed out, a net change of -2 holders.
  • The largest Assembly Biosciences buyer in Q1 2016 was QVT Financial, an estimated $1.15M added.
  • The largest Assembly Biosciences seller in Q1 2016 was Fidelity Investments, an estimated $1.48M sold.

Based on aggregated 13F filings for Q1 2016.